Biliary and pancreatic disease
Conditions
Interventions
Gold Standard:Pathological examination
combined 
with 
tumor 
markers 
Sponsors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Patients participate voluntarily and sign informed consent; (2) Aged 18-80 years; (3) Patients with biliary and pancreatic diseases (cholelithiasis, cholangiocarcinoma, pancreatic duct stones, pancreatitis, pancreatic pancreatic tumor, etc.) who planned to undergo EUS and ERCP.
Exclusion criteria
Exclusion criteria: (1) Patients with unstable vital signs and poor cardiopulmonary function who cannot tolerate endoscopic examination; (2) Women who are pregnant or lactating or who plan to become pregnant during the trial; (3) Less than 3 months after participating in or completing another clinical trial; (4) Other researchers consider it unsuitable for admission.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Consistent rate of positive detection;Consistent rate of negative detection;Overall detection consistency between the two groups; | — |
Secondary
| Measure | Time frame |
|---|---|
| Value for tumor staging;Cut-off value for cholangiocarcinoma;Cut-off value for pancreatic carcinoma; | — |
Countries
China
Contacts
Public ContactXiaohua Hou
Huazhong University of Science and Technology
Outcome results
None listed